Bempedoic acid for prevention of atherosclerotic cardiovascular disease: from trials to clinical practice
Nutrition, Metabolism and Cardiovascular Diseases · 2026-10 · 36 (10) · 104777
DOI: 10.1016/j.numecd.2026.104777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-10. Verfasst von Furio Colivicchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Reabilitation Cardiology, San Filippo Neri Hospital, Asl Rome 1, Rome, Italy. Electronic address: furio.colivicchi@aslroma1.it. Hauptthemen laut MEDLINE: Atherosclerosis, Fatty Acids, Dicarboxylic Acids, Dyslipidemias. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
AIMS: This viewpoint discusses the current role of bempedoic acid in clinical practice. DATA SYNTHESIS: Randomized clinical trials have shown bempedoic acid efficacy in both reducing LDL-C levels and major cardiovascular adverse events. This evidence has led to the inclusion of bempedoic acid among the lipid-lowering therapies with demonstrated clinical efficacy and recommended by the last update of European Society of Cardiology guidelines on dyslipidaemia management to prevent cardiovascular disease. CONCLUSIONS: Bempedoic acid is an important therapeutic option that overcomes some limitations of statins and allows to further reduce the global burden of atherosclerotic cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Reabilitation Cardiology, San Filippo Neri Hospital, Asl Rome 1, Rome, Italy. Electronic address: furio.colivicchi@aslroma1.it.
- Clinical and Reabilitation Cardiology, San Filippo Neri Hospital, Asl Rome 1, Rome, Italy. Electronic address: stefaniaa.difusco@aslroma1.it.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: marcello.arca@uniroma1.it.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy. Electronic address: maurizio.averna@unipa.it.
- Cardiology Unit, Perinei Hospital, Altamura, Italy. Electronic address: pietro.scicchitano@asl.bari.it.
- Cardiology Unit, Santo Spirito Hospital, Casale Monferrato, Alessandria, Italy. Electronic address: fnardi@aslal.it.
Zitieren
APA
Colivicchi, F., Di Fusco, S. A., Arca, M., Averna, M., Scicchitano, P., Nardi, F., & Catapano, A. L. (2026). Bempedoic acid for prevention of atherosclerotic cardiovascular disease: from trials to clinical practice. Nutrition, Metabolism and Cardiovascular Diseases, 36(10), 104777. https://doi.org/10.1016/j.numecd.2026.104777
Vancouver
Colivicchi F, Di Fusco SA, Arca M, Averna M, Scicchitano P, Nardi F, et al. Bempedoic acid for prevention of atherosclerotic cardiovascular disease: from trials to clinical practice. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(10):104777. doi:10.1016/j.numecd.2026.104777
BibTeX
@article{Colivicchi2026,
author = {Colivicchi, Furio and Di Fusco, Stefania Angela and Arca, Marcello and Averna, Maurizio and Scicchitano, Pietro and Nardi, Federico and Catapano, Alberico Luigi},
title = {Bempedoic acid for prevention of atherosclerotic cardiovascular disease: from trials to clinical practice},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {10},
pages = {104777},
doi = {10.1016/j.numecd.2026.104777}
}
EUVIMED